The Additional Prognostic Value of Tumor Volume Changes during Chemoradiotherapy in Patients with Stage III Non-Small Cell Lung Cancer
J Thorac Oncol
.
2018 Sep;13(9):e181-e182.
doi: 10.1016/j.jtho.2017.12.008.
Authors
Iris Walraven
1
,
Margriet Kwint
1
,
José Belderbos
2
Affiliations
1
Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
2
Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: j.belderbos@nki.nl.
PMID:
30166020
DOI:
10.1016/j.jtho.2017.12.008
No abstract available
Publication types
Letter
Comment
MeSH terms
Carcinoma, Non-Small-Cell Lung*
Chemoradiotherapy
Humans
Lung Neoplasms*
Neoplasm Staging
Prognosis
Spiral Cone-Beam Computed Tomography*
Tumor Burden